I had the honor of opening the MM&M Transforming Healthcare Conference in New York on 5 May, 2016, kicking off an agenda that explored all phases of the industry, from understanding the patient to the various clinical trials stages and considerations. Props to the MM&M team for assembling a diverse and engaging series of speakers and viewpoints, and thanks for including me.
Thoughts from the team
Disruptive innovation has made its way through most industries as a driving force for advancement and change.
But, the scientific research sector, whether public or private, has remained largely untouched by the benefits of disruptive innovation. The result? Two of life science’s biggest hurdles – astoundingly high lack of experimental reproducibility, and the fact that it continues to take 10+ years and over $2 billion to develop a life saving drug in the year 2016 – are still ongoing challenges.
Research scientists are swimming in data. Every day. Every experiment. The data and the integrity of the data are paramount.They provide documentation of scientific processes and hold keys to success, failure and reproducibility. But there is always missing data in most experimental research – information that you should have collected that gives context to the experimental data itself.
Virtually every startup team has ambitions to solve the world’s most pressing problems. Elemental Machines is no different.When we began contemplating our next adventure and looked at the world around us, our focus kept returning to the fact that, as a species, we have been able to survive (and thrive) on this planet because of our ability to invent our way out of the holes we’ve found ourselves in. This unique ability to innovate and discover new technologies has been a hallmark of human ingenuity. So we decided to focus on helping scientists discover more quickly and less expensively.